
Imivin Plus Injection
Marketer
Alniche Life Sciences Pvt Ltd
Salt Composition
Imipenem (1000mg) + Cilastatin (1000mg)
Overview Imivin Plus Injection
Combivir Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by healthcare professionals, it targets infectious agents to curtail further spread. Complete the prescribed dosage; discontinue only under medical guidance. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation. While typically resolving spontaneously, worsening symptoms necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness.
Uses of Imivin Plus Injection
Life-threatening bacterial illnesses
Major Benefits of Imivin Plus Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Imivin Plus Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imivin Plus Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Imivin Plus Injection works:
Imivin Plus Injection unites the antibiotic Imipenem with the dehydropeptidase I inhibitor Cilastatin. Imipenem combats bacterial infection by disrupting the synthesis of their protective cell wall, a crucial structure for their viability. Cilastatin's role is to prevent the enzymatic degradation of Imipenem (by dehydropeptidase I), thus extending its therapeutic effectiveness within the patient's system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Imivin Plus Injection's interaction with alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Imivin Plus Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Imivin Plus Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Imivin Plus Injection can induce adverse reactions that might impair driving ability. Certain side effects, including hallucinations (visual, auditory, or tactile), may impact a patient's capacity to operate a vehicle.
KidneyCAUTION
The use of Imivin Plus Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Imivin Plus Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Imivin Plus Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Imivin Plus Injection :
Omit a dose of Imivin Plus Injection? Seek your physician's advice.
Facts to Know About Imivin Plus Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Antimicrobial agents |
